David Linetsky, SVP, Life Sciences at Phreesia, Inc. (PHR), sold 720 shares at $29.50 ($21K) on 2025-02-05, disclosed to the SEC on 2025-02-07.
Scheduled sale ($21k) by SVP, Life Sciences under a pre-arranged 10b5-1 plan. Pre-set trade — not a discretionary signal on the stock.
Nothing distinguishes this filing.
| Filing → |
| PHR | SELL | 2026-01-20 | $127K | — | Filing → |
| PHR | SELL | 2026-01-12 | $104K | — | Filing → |
| PHR | SELL | 2025-12-19 | $2K | — | Filing → |